Nefazodone Hydrochloride
NDC 0093-1026, Nefazodone Hydrochloride, tablet, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-1026
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076037
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-1026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEFAZODONE HYDROCHLORIDE250 mg/1
Pharmacologic classes
Serotonin Reuptake Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-1026-06 | 00093102606 | 60 TABLET in 1 BOTTLE (0093-1026-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/51ff7db5-aaf9-4c3c-86e6-958ebf16b60f
Use it
Look up 0093-1026 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-1026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-1026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.